Brief: Oryzon Launches ABB Offer For €10 Mln Capital Increase
BRIEF-Oryzon Launches ABB Offer For €10 Mln Capital Increase June 30 (Reuters) - Oryzon Genomics SA ORY.MC:
LAUNCH OF ACCELERATED BOOK BUILDING OFFER
EXECUTES CAPITAL INCREASE BY MONETARY CONTRIBUTIONS OF 10 MILLION EUROS BY ISSUING AND PLACING INTO CIRCULATION ORDINARY SHARES WITH A PAR VALUE OF 0.05 EUROS EACH
TRANSACTION WILL BE CARRIED OUT THROUGH AN ACCELERATED BOOKBUILD OFFERING
FONDO DE IMPACTO SOCIAL COMMITS UP TO €25 MILLION FUTURE SUBSCRIPTION WITHIN 6 MONTHS
RESULTS OF PRIVATE PLACEMENT PROCEDURE ARE EXPECTED TO BE PUBLISHED ON JULY 1, 2026, PRIOR TO THE MARKET OPENING
NEW SHARES EXPECTED TO BE ADMITTED TO TRADING ON JULY 2, 2026 AND WILL START TRADING ON JULY 3, 2026
EFFECTIVE AMOUNT OF CAPITAL INCREASE MAY BE INCREASED UP TO 15 MILLION EUROS DEPENDING ON DEMAND
Source text: ID:nCNM7jmkc1
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28